Tony is a clinical researcher with an interest in Infection and Microbiology in Critically Ill Patients. He has investigated Infection, Antibiotics, Sepsis and Septic Shock.
He is the Chief Investigator for the NIHR-funded STRESS-L study which is investigating the use of beta blockade in patients treated in ICU with septic shock.
He works with the Microbiology Department in the University of Birmingham (UoB) studying Bacteriophage, MDR E coli and MicroRNA dynamics in the gut microbiome and also the Department of Clinical Bioinformatics (also UoB) investigating the management of patients undergoing Oesophagectomy and having treatment with Albumin.
He is working with members of the Turing Institute to analyse treatments used during the COVID-19 pandemic.